US Patent 10093686 Heteroaryl inhibitors of PDE4
Patent 10093686 was granted and assigned to Tetra Therapeutics on October, 2018 by the United States Patent and Trademark Office.
All edits
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+266 characters)
Article
Patent abstract
The present invention relates to compounds and methods useful as inhibitors of phosphodiesterase 4 (PDE4) for the treatment or prevention of inflammatory diseases and other diseases involving elevated levels of cytokines and proinflammatory mediators.
Edits on 1 Oct, 2023
Golden AI
Edits made to:
Infobox (+8 properties)
Infobox
Patent Inventor Names
A. Samuel Vellekoop0
Donna L. Romero0
Joel R. Walker0
Lei Zhu0
Mark E. Gurney0
Robert F. Campbell0
Timothy J. Hagen0
Xuesheng Mo0
Edits on 27 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 27 Apr, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 26 Mar, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 3 Aug, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 2 Feb, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 28 Jan, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 22 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10093686 Heteroaryl inhibitors of PDE4
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10093686
Date of patent
October 9, 2018
Patent application number
15680842
Date Filed
August 18, 2017
Patent primary examiner
Find more entities like US Patent 10093686 Heteroaryl inhibitors of PDE4
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.